Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
25
pubmed:dateCreated
2009-8-31
pubmed:abstractText
To evaluate the safety and efficacy of high-dose [(131)I]metaiodobenzylguanidine ([(131)I]MIBG) in the treatment of malignant pheochromocytoma (PHEO) and paraganglioma (PGL).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4162-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19636009-3-Iodobenzylguanidine, pubmed-meshheading:19636009-Adolescent, pubmed-meshheading:19636009-Adrenal Gland Neoplasms, pubmed-meshheading:19636009-Adult, pubmed-meshheading:19636009-Catecholamines, pubmed-meshheading:19636009-Child, pubmed-meshheading:19636009-Chromogranin A, pubmed-meshheading:19636009-Disease-Free Survival, pubmed-meshheading:19636009-Dose-Response Relationship, Radiation, pubmed-meshheading:19636009-Female, pubmed-meshheading:19636009-Humans, pubmed-meshheading:19636009-Infusions, Intravenous, pubmed-meshheading:19636009-Iodine Radioisotopes, pubmed-meshheading:19636009-Kaplan-Meier Estimate, pubmed-meshheading:19636009-Male, pubmed-meshheading:19636009-Middle Aged, pubmed-meshheading:19636009-Paraganglioma, pubmed-meshheading:19636009-Pheochromocytoma, pubmed-meshheading:19636009-Proportional Hazards Models, pubmed-meshheading:19636009-Prospective Studies, pubmed-meshheading:19636009-Radiopharmaceuticals, pubmed-meshheading:19636009-Risk Assessment, pubmed-meshheading:19636009-Time Factors, pubmed-meshheading:19636009-Treatment Outcome, pubmed-meshheading:19636009-Tumor Markers, Biological, pubmed-meshheading:19636009-Young Adult
pubmed:year
2009
pubmed:articleTitle
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
pubmed:affiliation
Department of Pediatrics, University of California, San Francisco, 350 Parnassus Ave, Suite 710, San Francisco, CA 94117, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Research Support, N.I.H., Extramural